Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SEPHIENCE sepiapterin 250 mg oral powder sachet - TGA Drug Approval Details

Approvals/TGA/SEPHIENCE sepiapterin 250 mg oral powder sachet

Approved

STANDARD

SEPHIENCE sepiapterin 250 mg oral powder sachet

PTC THERAPEUTICS AUSTRALIA PTY LIMITED🇦🇺 Therapeutic Goods Administration

Approval Date: Jul 22, 2025
Approval ID: d28bdd7c26653ba0
Company: PTC THERAPEUTICS AUSTRALIA PTY LIMITED
Type: Standard

Approval Details

Approval Id: d28bdd7c26653ba0
Product Name: SEPHIENCE sepiapterin 250 mg oral powder sachet
Artg Id: 453666
Artg Name: SEPHIENCE sepiapterin 250 mg oral powder sachet
Sponsor: PTC THERAPEUTICS AUSTRALIA PTY LIMITED
Artg Date: 2025-07-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Jul 22, 2025

Approval ID

d28bdd7c26653ba0

Type

Standard

Back to TGA Approvals